These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4798215)

  • 1. Chemotherapy of leishmaniasis: a method for screening potential leishmanicides.
    Mattock NM; Peters W
    Trans R Soc Trop Med Hyg; 1973; 67(1):22. PubMed ID: 4798215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental characteristics of the antileishmaniasis action of amphotericin B].
    Liubimov LK; Fateeva LI; Sergeeva LA
    Antibiotiki; 1979 Apr; 24(4):281-4. PubMed ID: 375822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experimental chemotherapy of leishmaniasis. I: Techniques for the study of drug action in tissue culture.
    Mattock NM; Peters W
    Ann Trop Med Parasitol; 1975 Sep; 69(3):349-57. PubMed ID: 1171658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of dog sarcoma and hamster peritoneal cells to Leishmania species.
    Mattock NM; Molyneux DH
    Trans R Soc Trop Med Hyg; 1973; 67(1):18. PubMed ID: 4798214
    [No Abstract]   [Full Text] [Related]  

  • 5. The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.
    Mattock NM; Peters W
    Ann Trop Med Parasitol; 1975 Sep; 69(3):359-71. PubMed ID: 1155997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experimental chemotherapy of leishmaniasis, V. The activity of potential leishmanicides against 'L. infantum LV9' in NMRI mice.
    Peters W; Trotter ER; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):289-97. PubMed ID: 7396563
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice.
    Weinrauch L; El-On J
    Trans R Soc Trop Med Hyg; 1984; 78(3):389-90. PubMed ID: 6087514
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphotericin B in resistant visceral leishmaniasis.
    Sahay AS; Jha TK
    Indian Pediatr; 1996 Jun; 33(6):499-501. PubMed ID: 8979611
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of leishmaniasis. Part VII: synthesis and bioevaluation of substituted terpenyl pyrimidines.
    Suryawanshi SN; Bhat BA; Pandey S; Chandra N; Gupta S
    Eur J Med Chem; 2007 Sep; 42(9):1211-7. PubMed ID: 17499393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental chemotherapy in hamsters, using paromomycin against 2 isolates of Leishmania mexicana and Leishmania braziliensis].
    Rezzano S; Moreno G; Scorza JV
    Rev Cubana Med Trop; 1982; 34(1):34-45. PubMed ID: 6750713
    [No Abstract]   [Full Text] [Related]  

  • 11. [South American leishmaniasis in medical practice. Therapeutic problems].
    Heimgartner E; Krebs A
    Schweiz Rundsch Med Prax; 1985 Jul; 74(29):779-83. PubMed ID: 3898301
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.
    Machado PR; Rosa ME; Guimarães LH; Prates FV; Queiroz A; Schriefer A; Carvalho EM
    Clin Infect Dis; 2015 Sep; 61(6):945-9. PubMed ID: 26048961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Role of Nanoparticles in Amphotericin B Delivery.
    Zaioncz S; Khalil NM; Mainardes RM
    Curr Pharm Des; 2017; 23(3):509-521. PubMed ID: 27799043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B in the treatment of visceral leishmaniasis.
    Croft SL; Davidson RN; Thornton EA
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():111-8. PubMed ID: 1778888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.
    Bryceson AD
    Trans R Soc Trop Med Hyg; 1970; 64(3):369-79. PubMed ID: 5453496
    [No Abstract]   [Full Text] [Related]  

  • 17. Late cutaneous leishmaniasis.
    Hart M; Livingood CS; Goltz RW; Totonchy M
    Arch Dermatol; 1969 Apr; 99(4):455-8. PubMed ID: 5769330
    [No Abstract]   [Full Text] [Related]  

  • 18. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
    Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
    Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
    Ortega V; Giorgio S; de Paula E
    J Liposome Res; 2017 Sep; 27(3):234-248. PubMed ID: 28874072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical localization of Leishmaniasis in an intestinal polyp.
    Zaffiri L; d'Ettorre G; Massetti AP; Mascellino MT; Mastroianni CM; Vullo V
    Infection; 2008 Mar; 36(2):187-8. PubMed ID: 18327682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.